EPA TRI Facility · Chemicals

Teva Pharmaceuticals USA

Mexico, MO · Parent: Teva Pharmaceuticals USA

Total releases
25.3K lbs
Chemicals reported
8
Carcinogens
2
Primary pathway
Air Releases
Verify at EPA TRI →

Teva Pharmaceuticals USA has reported 25.3K lbs of toxic releases across 8 chemicals to the EPA Toxic Release Inventory, based on annual facility disclosures from 2019 through 2023. Of the chemicals reported, 2 are classified as carcinogens, representing 25% of the facility's chemical profile. The facility operates in the Chemicals sector. The primary release pathway is air releases, accounting for 65% of total releases. All release data shown below is self-reported to the EPA under the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313.

#7,700 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk.

Teva Pharmaceuticals USA files annual Form R disclosures to the EPA Toxics Release Inventory under EPCRA Section 313, classified under NAICS 325412 (Chemicals). Across 2 years of records spanning 2019–2020, the site has disclosed 25.3K lbs in cumulative toxic releases across 8 distinct chemicals, 2 of which (25%) carry a carcinogenic classification.

The dominant release pathway is air releases at 16.5K lbs (65.3% of total volume), followed by off-site transfers at 34.7%. Between 2019 and 2020, reported totals decreased by 47% - from 16.5K lbs to 8.8K lbs. The facility is operated under parent company Teva Pharmaceuticals USA.

TRI Form R values are self-reported estimates, not measured stack emissions, and treat every pound of reported chemical equally regardless of toxicity. Inclusion in the TRI database does not establish a health risk to nearby residents; it documents the annual reporting record that Teva Pharmaceuticals USA has filed with the EPA under federal community right-to-know requirements.

Quick Facts

Industry
Chemicals
NAICS Code
325412
Total Releases
25.3K lbs
Chemicals Reported
8
Latest Report Year
2020

Compare this facility

See how Teva Pharmaceuticals USA stacks up against nearby facilities and the typical reporter.

Total reported releases
Teva Pharmaceuticals USA
25.3K lbs
Buick Mine/mill
48.2M lbs

100% less than the comparison

Chemicals reported
Teva Pharmaceuticals USA
8
Buick Mine/mill
8

About the same as the comparison

Comparison reflects reported pounds and chemical counts, not toxicity or health risk. Averages cover facilities reporting any release.

How does this facility release toxic chemicals?

How Teva Pharmaceuticals USA releases toxic chemicals into the environment. Total: 25.3K lbs.

Air Releases 16.5K lbs (65.3%)
Off-site Transfers 8.8K lbs (34.7%)
View 2-Year Emissions Trend →

Emissions Trend Summary

From 2019 to 2020, total releases decreased by 47% (16.5K lbs to 8.8K lbs).

Reported total releases by year

Teva Pharmaceuticals USA - annual TRI totals

million lbs

What this shows Year-over-year reported totals. TRI figures are self-reported estimates and can swing with production levels, waste-rock handling and reporting changes, not only with emissions controls.

Source EPA Toxics Release Inventory (TRI)
Year Total Chemicals
2019 16.5K lbs 8
2020 8.8K lbs 6

Chemical Releases

Aggregated across all reporting years (2019–2020). 2 of 8 chemicals are carcinogens. Sorted by total release volume.

Chemical Total Flags
Ammonia 9.3K lbs -
Dichloromethane 8.2K lbs Carcinogen
Toluene 6.3K lbs -
Methanol 1.3K lbs -
Triethylamine 116 lbs -
N,N-Dimethylformamide 106 lbs Carcinogen
Hydrochloric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size) 0 lbs -
Sulfuric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size) 0 lbs -

Location

Coordinates
39.1507, -91.8246
ZIP Code
65265
EPA Facility ID
65265BCRFT5000C

About TRI Data

Data as of 2023 reporting year. Source: U.S. Environmental Protection Agency (EPA) Toxic Release Inventory.

Data comes from the EPA Toxic Release Inventory (TRI) program. Facilities that manufacture, process, or otherwise use listed toxic chemicals above threshold amounts are required to report annually to the EPA.

Release quantities are self-reported by the facility and may represent estimates rather than exact measurements. "Total releases" includes releases to air, water, land, and off-site transfers for disposal. Quantities shown here are aggregated across all available reporting years.

PlainEnviro presents this data without advocacy framing. The presence of a facility in the TRI database does not by itself indicate a health risk. For site-specific health questions, consult your local environmental or health agency.

Frequently Asked Questions

What chemicals does Teva Pharmaceuticals USA release?
Teva Pharmaceuticals USA has reported releases of 8 chemicals to the EPA Toxic Release Inventory, totaling 25.3K lbs. 2 of these (25%) are classified as carcinogens.
What industry is Teva Pharmaceuticals USA in?
Teva Pharmaceuticals USA is classified under the "Chemicals" industry (NAICS code 325412), located in Mexico, MO.
How long has Teva Pharmaceuticals USA reported to the TRI?
Teva Pharmaceuticals USA has EPA Toxic Release Inventory data spanning 2 years, from 2019 to 2020.
How does Teva Pharmaceuticals USA release toxic chemicals?
The primary release pathway for Teva Pharmaceuticals USA is air releases, accounting for 65.3% of total releases (16.5K lbs). Secondary pathway: off-site transfers (34.7%).
Are emissions from Teva Pharmaceuticals USA increasing or decreasing?
From 2019 to 2020, total releases decreased by 47%, from 16.5K lbs to 8.8K lbs.
Is Teva Pharmaceuticals USA a health risk?
The presence of a facility in the TRI database does not by itself indicate a health risk. Release quantities are self-reported estimates. For site-specific health questions, consult your local environmental or health agency.
Does Teva Pharmaceuticals USA release carcinogens?
Yes, Teva Pharmaceuticals USA reports 2 chemicals classified as carcinogens, representing 25% of all chemicals reported by this facility. Carcinogen classification is based on EPA and IARC assessments.

What to do with this facility's data

Use this facility profile as a starting point, then check how it compares.

  • See whether releases reported by Teva Pharmaceuticals USA are rising or falling over time. View trends
  • This facility ranks #7,700 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk. See the full rankings
  • Check Missouri's statewide profile for the full picture: total facilities, water systems, and Superfund sites. View Missouri profile

TRI release totals are self-reported estimates submitted to the EPA, not independently measured stack emissions; a high rank reflects reported volume, not necessarily local health risk.

Related

Sources & how this page was built

Every figure on this page traces to public, federal-government data on Teva Pharmaceuticals USA. The records below are the primary sources; our methodology explains how they are joined, computed, and verified.

Retrieved and formatted by PlainEnviro Editorial. TRI release totals are self-reported estimates, not measured stack emissions.

According to the U.S. Environmental Protection Agency, the Toxics Release Inventory has required annual industrial disclosure since its creation under the Emergency Planning and Community Right-to-Know Act in October 1986, and this facility's record is drawn from PlainEnviro's database of more than 25,000 EPA-tracked facilities through the 2023 reporting year; see our methodology for full source citations and refresh cadence.